-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Friday Satellite Symposia

Friday, December 6, 2024

Friday | top

7:00 AM-10:00 AM

Addressing Current Questions and Controversies in the Management of Chronic Lymphocytic Leukemia – What Clinicians Want to Know
Addressing Current Questions and Controversies in the Management of Chronic Myeloid Leukemia - What Clinicians Want to Know
An Interactive Case-based Review of Chronic Lymphocytic Leukemia: Experts Explore the Latest Evidence and Guideline Updates
Bridging Gaps in Multiple Myeloma Care: A Community Oncologist's Guide to Navigating the Evolving Treatment Landscape
Championing the Care of Relapsed/Refractory Multiple Myeloma: Practical Strategies to Integrate Bispecific Antibodies
Mastering the Art of Myelofibrosis Care: Expert Guidance, Clinical Experience + Innovation for More Personalized Disease Control
MDS 2024: Let’s Overcome the Challenges
Shifting to Higher Standards in MDS: Custom and Innovative Care to Improve Outcomes for Lower- and Higher-Risk Disease

11:00 AM-2:00 PM

Addressing Current Questions and Controversies in the Management of Myelofibrosis - What Clinicians Want to Know
Addressing Current Questions and Controversies Regarding the Role of CAR T-Cell Therapy and Bispecific Antibodies in the Management of Lymphoma - What Clinicians Want to Know
A Game Changer for Follicular Lymphoma: Mastering Use of Precision Therapies as Part of a Chemo-free Treatment Paradigm
A New Era for Hemophilia Treatment: Common Goals, Unique Perspectives
Application of Evolving Evidence in Mantle Cell Lymphoma: Therapeutic Strategies Using BTK Inhibitors
A Violent Graft in a Vulnerable Host: The Future of aGVHD Management
Collaborating for Optimal Immune Thrombocytopenia Care: Uniting Disease, Treatment, and Patient-Centered Considerations
Crafting Custom Care in CLL: Guidance on Upfront and Sequential Treatment Decisions With Targeted and Immune-based Platforms
Escape the Amyloid Maze: Unraveling Data and Care Strategies for AL Amyloidosis
Evolving Treatment Paradigms for Patients with Hemoglobinopathies
From Barriers to Breakthroughs in Multiple Myeloma: How Trials Compare to the Real-World Management of Patients in Your Practice
Guiding Our Patient's Path: Managing First Relapse in Diffuse Large B-Cell Lymphoma Outside of CAR Ts
Maximizing Touchpoints to Empower Impactful Patient-Centered Care for Paroxysmal Nocturnal Hemoglobinuria
Medical Crossfire®: Bridging Evidence to Practice in AML... Updates on FLT3, IDH1/2, Maintenance, Combos, and Clinical Trials
Next Up: Conversations On Optimizing CD38 Antibody-Based Triplet Regimens For Early-Relapse Multiple Myeloma
Treatment Crossroads: Diverse Perspectives on Treatment Strategies for Relapsed/Refractory DLBCL and FL

3:00 PM-6:00 PM

Addressing Current Questions and Controversies in the Management of Acute Myeloid Leukemia - What Clinicians Want to Know
Addressing Current Questions and Controversies in the Management of Multiple Myeloma - What Clinicians Want to Know
A Step-By-Step Approach to CAR T-cell Therapy for RRMM: From Bridging to Sequencing and Adverse Event Management
Bispecific Antibodies: A Playbook for Relapsed/Refractory Follicular Lymphoma
Cases and Conversations™: The Rationale for Utilizing Non-Factor Replacement Therapies in Hemophilia Care
Clinical assessment of gene therapies for hemophilia A and hemophilia B: Key takeaways for your practice
Complex Cases in the Community Clinic: Managing Diverse Hematologic Malignancies
Medical Crossfire®: Bridging Expert Guidance and Evidence-Based Recommendations in the Ever-Evolving Treatment of MF, PV, and ET
Medical Crossfire®: New Horizons in Acute Lymphoblastic Leukemia—How The Experts Apply New Evidence from AYA to Adult Scenarios
Sharing Best Practices from the ALL/LBL Clinic: Navigating Patient-Centered Care with Asparaginase Therapies
Unleashing Emerging Therapies to Modify Myelofibrosis Pathogenesis: Shifting the Treatment Paradigm to Target Deeper Clinical and Molecular Responses

7:00 PM-10:00 PM

Accelerating the Adoption of the Latest Evidence on Sequencing Therapies for Multiple Myeloma Across Practice Settings
How We Do It®: New Combinations Reshaping Treatment Decision-Making in Newly Diagnosed Multiple Myeloma
Show Me the Data™: How Do We Navigate the Latest Evidence on Novel Therapies and Trials Across GvHD Prophylaxis, Acute, and Chronic Care?
Show Me the Data™: Pushing CAR T’s Forward Across Lymphoid Malignancies... Accelerating Access in the Community and Treatment Strategies for the Road Ahead